19
Apr, 2000
Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis
Authors: Sharland M, Gibb DM, Giaquinto C.
Published in: European Journal of Pediatrics 2000; 159:649-656.
19
Apr, 2000
Authors: Sharland M, Gibb DM, Giaquinto C.
Published in: European Journal of Pediatrics 2000; 159:649-656.
19
Apr, 2000
Authors: Bernardi S, Thorne C, Newell ML, Giaquinto C,Tovo PA, Rossi P.
Published in: European Journal of Pediatrics 2000; 159(3):170-5
18
Apr, 2000
Authors: King D, Gibb DM, Gotch F, Larsson-Sciard E.
Published in: 7th Conference on Retroviruses and Opportunistic Infections, January 30th- February 2nd, 2000, Abstract 322., San Francisco. Abstract 322
18
Apr, 2000
Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Wörner I, Babiker A
Published in: Lancet.2000; 355: 1331-2
Abstract In 25 vertically HIV-infected children receiving highly-active antiretroviral therapy, a 3-log10 reduction in plasma HIV RNA load was maintained for 1 year and was associated with a doubling of the CD4-cell percentage. Most (75%) new CD4 cells carried the CD45RA marker of naive cells and there was only a small rise in memory cells (CD45RO). This pattern of immune restoration differs from adults, and may be due to the presence of a functioning thymus in children.
18
Apr, 2000
Authors: Gibb. D. M. for the PENTA 5 Executive and the PENTA Steering Committee.
Published in: Oral presentation at 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000 also published in AIDS 2000, Vol 14, supp4 p.58 (abstractPL6.8)
18
Apr, 2000
Authors: Kaye S. on behalf of the PENTA Virology Committee.
Published in: 5th International Congress on Drug Therapy in HIV Infection, October 22nd-26th 2000, Glasgow. P_308.
